Haohai Biological Technology (688366): Short-term performance under pressure; operating trends expected to improve in 2H26

Key Investment ThesisThe company's performance in the first half of 2026

Citic SecuritiesSep 30 00:00

Zhitong Statistics on Abnormal Changes in Hong Kong Stock Connect Holdings | September 23

Smart-Hong Kong Stock Connect Proportion Volatility Statistics | September 22, 2026 Zhitong Finance APP learned that, according to data disclosed on September 22, 2026, Health160 (02656), Cambridge

Zhitong FinanceSep 23 08:36

September 21 Share Buyback Summary | Tencent and HSBC Holdings, among others, conducted share buybacks, with Tencent spending HK$101 million.

According to documents disclosed by the Hong Kong Exchange on September 22,$Tencent (00700.HK)$、$HSBC Holdings (00005.HK)$Pending share repurchase.① $Tencent (00700.HK)$On September 21, the company

Futu NewsSep 22 09:20

Haohai Biological Technology (06826.HK) repurchased 27,500 shares on September 21 at a total cost of HK$438,300.

Gelonghui, September 21 — Haohai Biotechnology (06826.HK) announced that on September 21, 2026, it repurchased 27,500 shares at a total cost of HK$438,300, at prices ranging from HK$15.80 to HK$15.96

GelonghuiSep 21 17:22

Share Buyback Roundup for September 18: Companies including Tencent and Baidu Group-W conducted share repurchases, with Tencent spending HK$100 million.

According to documents disclosed by the Hong Kong Exchange on September 21,$Tencent (00700.HK)$、$Baidu Group-W(09888.HK)$Pending share repurchase.① $Tencent (00700.HK)$On September 18, the company

Futu NewsSep 21 09:30

Haohai Biological Technology: Repurchased 67,000 H-shares on September 18

Gelonghui, September 18 | Haohai Biotechnology announced that on September 18, 2026, the company repurchased 67,000 H shares through the Hong Kong Stock Exchange at a price of HK$15.2 per share, for

Gelonghui FinanceSep 18 17:49